Patent · US Active

Susceptibility variants for lung cancer

US8828657B2 · kind B2 · utility

4Cited by
19References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 16, 2009
Grant dateSep 9, 2014
Priority date
Expiry dateFeb 16, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/172
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention discloses certain genetic variants as susceptibility variants for lung cancer. The invention relates to methods of risk assessment using such variants. The invention further relates to kits for use in risk assessment of lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.